GRIFOLS | GRF - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Alcon AG USD 54M 3M 2025-12
Amadeus IT EUR 20.8M 200K 2025-12
Amarin USD 3K 5K 2024-12
argenx SE USD 828K 165K 2025-12
AstraZeneca USD 484M 181M 2025-12
Bayer EUR 675M 87M 2025-12
Demant DKK 398M 37M 2025-12
Ence Energia y Celulosa EUR 16.2M 7.1M 2025-12
Essilor EUR 147M 102.5M 2025-06
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 85M 8.1M 2025-12
Galapagos EUR 1.72M 940K 2025-09
Genmab DKK 10M 27M 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Inditex EUR 31M 22M 2025-12
Merck EUR 121M 5M 2025-12
Novartis USD 304M 23M 2025-12
Philips EUR 109M 31M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR -25M 252M 2025-12
Smith & Nephew USD 69M 1000K 2025-12
UCB EUR 49M 29M 2025-12
Viscofan EUR 2.36M 93K 2025-12